|
|
|||||||||
|
|
NeoReviews Vol.8 No.4 2007 e152
© 2007 American Academy of Pediatrics
,
,
* Child Research Institute, Child, Youth and Women's Health Service, North Adelaide, Australia
Child Health Research Institute at Flinders, Flinders Medical Centre, Bedford Park, Australia
School of Paediatrics and Reproductive Health, University of Adelaide, Australia
School of Agriculture, Food and Wine, University of Adelaide, Australia
Prenatal supplements containing n-3 long-chain polyunsaturated fatty acids (LCPUFA) are becoming popular with pregnant women, primarily because of the suggestion that an increased supply of docosahexaenoic acid (DHA), a key n-3 LCPUFA, may be important to fetal brain development. Current research data suggest that routine use of marine oil supplements in pregnancy probably has little benefit in preventing pre-eclampsia, preterm birth, and low birthweight, although its use is safe during pregnancy. There is a suggestion that dietary DHA insufficiency may be associated with symptoms of postnatal depression; randomized, controlled studies are needed to investigate this possibility. The effect of a DHA-rich marine oil intervention in pregnancy on long-term development of children is under investigation. The possibility that maternal marine oil supplementation may modify neonatal immune function requires further investigation.
Abbreviations: AA: arachidonic acid CI: confidence interval DHA: docosahexaenoic acid EPA: eicosapentaenoic acid LCPUFA: long-chain polyunsaturated fatty acid RR: relative risk WMD: weighted mean difference
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | CME | ARCHIVE | SEARCH | TABLE OF CONTENTS |